Gilead Sciences (GILD) Debt Ratio (2009 - 2026)
Gilead Sciences' (GILD) quarterly Debt Ratio came in at 0.58 in Q2 2026, up 16.58% on a YoY basis from 0.5 in Q2 2025, and up 39.12% quarter-over-quarter from 0.42 in Q1 2026.
Analysis
Gilead Sciences (GILD) Debt Ratio (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has reported Debt Ratio for 18 consecutive years, with 0.58 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Debt Ratio rose 16.58% year-over-year to 0.58; the trailing twelve-month figure through Jun 2026 stood at 0.58 (up 16.58% YoY), and the FY2025 full-year result was 0.47, down 2.78% from the prior year.
- Debt Ratio rose to 0.58 in Q2 2026 per GILD's latest filing, from 0.42 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.58 in Q2 2026 and bottomed at 0.42 in Q1 2026.
- Historically, Debt Ratio has averaged 0.47 across 5 years, with a median of 0.46 in 2024.
- The widest YoY moves for Debt Ratio: up 16.58% in 2026, down 15.15% in 2026.
- Over 5 years, Debt Ratio stood at 0.44 in 2022, then decreased by 0.97% to 0.43 in 2023, then advanced by 12.15% to 0.48 in 2024, then fell by 2.78% to 0.47 in 2025, then increased by 23.52% to 0.58 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.58, 0.42, and 0.47 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 0.05 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 0.05 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.25 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Insmed | 27.67 Bn | 26.51 Bn | 358.27 Mn | 0.26 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.58 |
| Mar 31, 2026 | 0.42 |
| Dec 31, 2025 | 0.47 |
| Sep 30, 2025 | 0.47 |
| Jun 30, 2025 | 0.50 |
| Mar 31, 2025 | 0.49 |
| Dec 31, 2024 | 0.48 |
| Sep 30, 2024 | 0.46 |
| Jun 30, 2024 | 0.47 |
| Mar 31, 2024 | 0.51 |
| Dec 31, 2023 | 0.43 |
| Sep 30, 2023 | 0.43 |
| Jun 30, 2023 | 0.47 |
| Mar 31, 2023 | 0.44 |
| Dec 31, 2022 | 0.44 |
| Sep 30, 2022 | 0.44 |
| Jun 30, 2022 | 0.43 |
| Mar 31, 2022 | 0.43 |
| Dec 31, 2021 | 0.42 |
| Sep 30, 2021 | 0.45 |